Supriya Lifescience Limited (NSE: SUPRIYA)

Supriya Lifescience Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Operating Revenue	5,990	5,704	4,609	5,300	3,912	3,116
Other Revenue	-	-	-	-	-	83.55
Revenue	5,990	5,704	4,609	5,300	3,912	3,200
Revenue Growth (YoY)	21.84%	23.74%	-13.04%	35.49%	22.26%	13.54%
Cost of Revenue	2,231	2,322	1,961	2,035	1,329	1,460
Gross Profit	3,759	3,381	2,649	3,266	2,583	1,740
Selling, General & Admin	722.94	862.26	730.21	655.81	501.41	345.47
Other Operating Expenses	1,125	-2,250	628.48	465.44	350.31	323.18
Operating Expenses	2,013	-1,230	1,477	1,222	919.33	732.41
Operating Income	1,745	4,611	1,172	2,043	1,664	1,008
Interest Expense	-16.29	-3,060	-30.84	-41.98	-40.8	-68.49
Interest & Investment Income	-	83.57	95.16	70.94	49.91	21.73
Currency Exchange Gain (Loss)	-	-	-	-	-	-4.45
Other Non Operating Income (Expenses)	99.43	0.01	-0.02	0.1	0.13	5.18
EBT Excluding Unusual Items	1,828	1,635	1,236	2,072	1,673	962.04
Gain (Loss) on Sale of Investments	-	22.4	-	-	-	-
Gain (Loss) on Sale of Assets	-	-	-1.11	-	-	-
Pretax Income	1,828	1,657	1,235	2,072	1,673	962.27
Income Tax Expense	475.81	465.76	336.3	554.35	437.16	228.24
Net Income	1,352	1,191	898.57	1,518	1,236	734.03
Net Income to Common	1,352	1,191	898.57	1,518	1,236	734.03
Net Income Growth	45.24%	32.56%	-40.81%	22.83%	68.38%	86.19%
Shares Outstanding (Basic)	80	80	80	80	73	73
Shares Outstanding (Diluted)	80	80	80	80	73	73
Shares Change (YoY)	-0.07%	-	-	9.97%	-	-
EPS (Basic)	16.80	14.80	11.16	18.86	16.89	10.03
EPS (Diluted)	16.80	14.80	11.16	18.86	16.89	10.03
EPS Growth	45.34%	32.62%	-40.83%	11.68%	68.38%	86.19%
Free Cash Flow	-	-323.48	-443.05	-111.03	276.48	915.37
Free Cash Flow Per Share	-	-4.02	-5.50	-1.38	3.78	12.51
Dividend Per Share	-	0.800	0.600	0.600	0.540	2.000
Dividend Growth	-	33.33%	0%	11.11%	-73.00%	-
Gross Margin	62.75%	59.28%	57.46%	61.61%	66.03%	54.39%
Operating Margin	29.14%	80.84%	25.42%	38.55%	42.53%	31.50%
Profit Margin	22.58%	20.88%	19.49%	28.64%	31.59%	22.94%
Free Cash Flow Margin	-	-5.67%	-9.61%	-2.09%	7.07%	28.61%
EBITDA	1,915	4,761	1,281	2,136	1,724	1,064
EBITDA Margin	31.98%	83.47%	27.80%	40.31%	44.06%	33.26%
D&A For EBITDA	170.24	149.62	109.7	93.01	60	56.15
EBIT	1,745	4,611	1,172	2,043	1,664	1,008
EBIT Margin	29.14%	80.84%	25.42%	38.55%	42.53%	31.50%
Effective Tax Rate	26.02%	28.11%	27.23%	26.75%	26.13%	23.72%
Revenue as Reported	279.12	5,810	4,704	5,376	3,962	3,227
Advertising Expenses	-	185.39	173.92	165.03	173.8	89.56

Source: S&P Capital IQ. Standard template. Financial Sources.